INFU
InfuSystem Holdings, Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
InfuSystem (INFU) Stock: Buy, Sell, or Hold?
$15.08
-0.20 (-1.31%)
▼
5d:
+14.68%
30d:
+11.79%
90d:
+20.83%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (40%)
Quality Score
42/100
Position
EXTENDED
30-Day Fair Range
$13.31 – $14.41
Position: EXTENDED
Forward P/E & Valuation
29.0x
STRETCHED
vs 20.4x historical avg
Wall Street Target
$17.50
+16.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$12.34 / $15.47
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: INFU shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When INFU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.92
Based on 8.5% avg growth
INTRINSIC VALUE TODAY
$9.88
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INFU is currently trading at $15.08, which is considered extended relative to its 30-day fair value range of $13.31 to $14.41. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.0) compared to its historical average (20.4). At these levels, the market is pricing in 12.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INFU is in a strong uptrend. The price is approaching resistance at $15.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INFU scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $17.50 (+16.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INFU is in a strong uptrend. The price is approaching resistance at $15.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INFU scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $17.50 (+16.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.31 -
$14.41
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
39.6%
Trading Range & Key Levels
30-Day Trading Range
$13.31 -
$14.41
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.03
(6.8%)
Support Level
$12.34
Resistance Level
$15.47
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($17.50)
- NEUTRAL: Trading at premium valuation - market expects 12.4% growth which is achievable
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
29.00
Wall Street Target
$17.50
(+16.0%)
Revenue Growth (YoY)
3.0%
Earnings Growth (YoY)
36.4%
Profit Margin
6.5%
Valuation Premium vs History
+12.4% premium
PE vs Historical
29.0 vs 20.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+12.4%
(market-implied from PE analysis)
1-Year Target
$16.95
(+12%)
2-Year Target
$19.05
(+26%)
3-Year Target
$21.41
(+42%)
3-Yr Target (if PE normalizes)
(PE: 29→20)
PE COMPRESSION
$15.06
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.0, Growth: 13.0%)
$21.78
(+45%)
Base:
(SPY PE: 19.9, Growth: 13.0%)
$14.92
(-1%)
Bear:
(PE: 16.9, Growth: 13.0%)
$12.68
(-16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (29x PE) as earnings recover.
Trailing PE: 34.73 | Current EPS (TTM): $0.44
Bull Case
$19.86
(+32%)
Analyst growth 18.2%, PE expands to 38.2
Base Case
$18.06
(+20%)
Market implied 18.2%, PE stable at 34.7
Bear Case
$10.39
(-31%)
Severe decline -20.0%, PE contracts to 29.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share INFU Analysis
Share this live INFU analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INFU)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
InfuSystem reported record revenue and expanded margins in Q3 2026, reaffirming full-year guidance despite temporary working capital pressure.
Key Retail Themes:
Strong financial performance
Positive outlook
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:29 PM ET
Data refreshes hourly during market hours. Next update: 9:29 PM
Data refreshes hourly during market hours. Next update: 9:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INFU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 38 SELL |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 38 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
22 analysts |
$88 | 30 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INFU Research Pages
